CG Asset Management’s AbbVie ABBV Stock Holding History

CG Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.62M	Buy	41,885 +700	+2%	+$42.7K	0.98%	36
2016 Q3	$2.6M	Buy	41,185 +325	+0.8%	+$21K	0.97%	33
2016 Q2	$2.53M	Sell	40,860 -1,720	-4%	-$105K	1.01%	34
2016 Q1	$2.43M	Sell	42,580 -11,600	-21%	-$647K	0.97%	37
2015 Q4	$3.21M	Buy	54,180 +10,600	+24%	+$611K	1.28%	28
2015 Q3	$2.37M	Sell	43,580 -100	-0.2%	-$6.51K	1%	37
2015 Q2	$2.94M	Buy	43,680 +550	+1%	+$35.9K	1.12%	30
2015 Q1	$2.52M	Sell	43,130 -2,050	-5%	-$124K	0.98%	37
2014 Q4	$2.96M	Sell	45,180 -750	-2%	-$47.3K	1.17%	34
2014 Q3	$2.65M	Buy	45,930 +200	+0.4%	+$11.1K	1.09%	35
2014 Q2	$2.58M	Sell	45,730 -11,500	-20%	-$603K	1.09%	35
2014 Q1	$2.94M	Buy	57,230 +2,000	+4%	+$101K	1.32%	27
2013 Q4	$2.92M	Buy	+55,230	New	+$2.71M	1.34%	29

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CG Asset Management's ABBV Position: Q4 2016 in Review

CG Asset Management increased its AbbVie (ABBV) stake by 1.7% in Q4 2016, buying an estimated $42.7K and bringing the position to 41,885 shares worth $2.62M. The position accounts for 0.98% of the portfolio, ranked #36.

CG Asset Management first reported a position in ABBV in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.21M in Q4 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

CG Asset Management held 41,885 shares of AbbVie worth $2.62M as of Q4 2016.
CG Asset Management bought 700 AbbVie shares in Q4 2016, an estimated $42.7K.
AbbVie made up 0.98% of CG Asset Management's portfolio in Q4 2016, its #36 holding.
CG Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 13 quarters since.
CG Asset Management's AbbVie position peaked at $3.21M in Q4 2015.
1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.